The markets traded mixed during the midday with the Dow falling 37 points to 17,702 as crude oil prices slipped below $44 per barrel. Nasdaq gained 23 points to 4,759.
On the upside
Mizuho upgraded DepoMed (Nasdaq: DEPO) from a Neutral rating to a Buy rating.
Chimerix (Nasdaq: CMRX) reported upbeat interim results from an AdVise trial of brincidofovir.
Ceragon Networks (Nasdaq: CRNT) narrowed first quarter losses more than expected.
On the downside
Tetra Technologies (NYSE: TTI) widened first quarter losses more than expected as revenue tumbled.
A drop in the Shanghai markets sent shares of Momo (Nasdaq: MOMO) lower.
AngloGold Ashanti (NYSE: AU) reported lower first quarter earnings as production dropped.
In the broad market, declining issues outpaced advancers by a margin of nearly 10 to 9 on the NYSE while advancers edged out decliners by a margin of nearly 3 to 2 on Nasdaq. The broader S&P 500 added 2 points to 2,059. Bitcoin rose $4 to $459.
